Clinical Trial Update: Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon [Phase 3]

View source ↗

Summary

Phase 3 trial comparing standard high-dose alpha interferon with intermittent high-dose alpha interferon in adjuvant Stage III melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Dermatologic Cooperative Oncology Group | Conditions: Adjuvant, Stage III Malignant Melanoma | Phase 3 | Status: UNKNOWN